glaucoma rs pirngadi
TRANSCRIPT
-
8/17/2019 Glaucoma rs pirngadi
1/30
GLAUCOMA
Z A L D I
FAKULTAS KEDOKTERAN
UNIVERSITAS ISLAM SUMATERA UTARA
MEDAN
2014
5/1/16GLAUCOMA
Z A L D I1
-
8/17/2019 Glaucoma rs pirngadi
2/30
Global causes of VisualImpairment, inclusive ofblindness, as percentage
5/1/16GLAUCOMA
Z A L D I2
-
8/17/2019 Glaucoma rs pirngadi
3/30
Global causes of blindness aspercentage of global blindness in 2010
5/1/16GLAUCOMA
Z A L D I3
-
8/17/2019 Glaucoma rs pirngadi
4/30
CATEGORY OF VISUAL ACUITY
5/1/16GLAUCOMA
Z A L D I4
-
8/17/2019 Glaucoma rs pirngadi
5/30
DEFINITION
• Glaucoma is a o!"ic #u$o!a"%&'%ic% is c%a$ac"#$i(#) *&+
– O!"ic #$,# -*#$s )#a"% o!"ic )isc
)ama.#/
– $o.$#ssi,# ,isual -#l) )##c"
– $#)is!osi. ac"o$ is I"$a ocula$
!$#ssu$# 3IO1 5i.% "#sio .laucoma
2 No$mo "#sio .laucoma
6 Lo' "#sio .laucoma5/1/16 GLAUCOMAZ A L D I 5
-
8/17/2019 Glaucoma rs pirngadi
6/30
MORTALITY 7 MOR8IDITY
• Glaucoma is "%# "%i$) l#a)i. caus#o *li)#ss i "%# US
• T%# $is9 o *#comi. l#.all& *li) io# # $om o!#:a.l# .laucoma isa!!$o;ima"#l& 20
-
8/17/2019 Glaucoma rs pirngadi
7/30
EA!I"A#I$"
• FUNDUSCOY
• TONOMETRY
• SLITLAM
• GONIOSCOY
• OCT 3 OTICAL
CO5ERENCE TOMOGRA5Y
5/1/16GLAUCOMA
Z A L D I7
-
8/17/2019 Glaucoma rs pirngadi
8/30
TONOMETRY
5/1/16 GLAUCOMA
Z A L D I8
-
8/17/2019 Glaucoma rs pirngadi
9/30
GONIOSCOY
5/1/16 GLAUCOMA
Z A L D I9
-
8/17/2019 Glaucoma rs pirngadi
10/30
GOLDMAN ERIMETRY
5/1/16 GLAUCOMA
Z A L D I10
-
8/17/2019 Glaucoma rs pirngadi
11/30
GLAUCOMA
A% &'I!A'( GLA)*$!A
1 O!#:a.l# .laucoma
a $ima$& o!#:a.l# .laucoma
* No$mal:"#sio .laucoma 3lo':"#sio .laucoma
2 A.l#:closu$# .laucoma
a Acu"#
* Su*acu"#
c C%$oic
) la"#au i$is
+% *$"GE"I#AL GLA)*$!A
*% E*$"DA'( GLA)*$!A
5/1/16 GLAUCOMAZ A L D I
11
-
8/17/2019 Glaucoma rs pirngadi
12/30
AQUEOUS HUMOUR OUTFLOW SYSTEM
5/1/16 GLAUCOMAZ A L D I
12
-
8/17/2019 Glaucoma rs pirngadi
13/30
5/1/16 GLAUCOMAZ A L D I
13
-
8/17/2019 Glaucoma rs pirngadi
14/30
E#I$L$G(
• T%$## ac"o$s)#"#$mi# "%# IO + – $o)uc"io %umo$
a?u#ous
– R#sis"ac# "oa?u#ous ou"@o'ac$oss "$a*#cula$m#s%'o$9:caal
sc%l##ms s&s"#m – T%# l#,#l o #!iscl#$al
,#ous !$#ssu$#
5/1/16 GLAUCOMAZ A L D I
14
-
8/17/2019 Glaucoma rs pirngadi
15/30
CLASSIFICATION
5/1/16 GLAUCOMAZ A L D I
15
-
8/17/2019 Glaucoma rs pirngadi
16/30
&A#$GE"EI
5/1/16 GLAUCOMAZ A L D I
16
-
8/17/2019 Glaucoma rs pirngadi
17/30
5/1/16 GLAUCOMAZ A L D I
17
-
8/17/2019 Glaucoma rs pirngadi
18/30
DIRECT
OPHTHALMOSCOPY
5/1/16 GLAUCOMAZ A L D I
18
-
8/17/2019 Glaucoma rs pirngadi
19/30
FUNDUSCOY
OPTIC NEUROPATHY
S5AE
DEMARCATION
CU DISC RATIO
CUING 7ECAVATION
S5IFT 7NASALISATION
ATRO5Y
5/1/16 GLAUCOMAZ A L D I
19
-
8/17/2019 Glaucoma rs pirngadi
20/30
5/1/16 GLAUCOMAZ A L D I
20
-
8/17/2019 Glaucoma rs pirngadi
21/30
VI)AL -IELD
5/1/16 GLAUCOMAZ A L D I
21
-
8/17/2019 Glaucoma rs pirngadi
22/30
#.E "$'!AL VI)AL-IELD
5/1/16 GLAUCOMAZ A L D I
22
-
8/17/2019 Glaucoma rs pirngadi
23/30
5/1/16 GLAUCOMAZ A L D I
23
GLAUCOMAGLAUCOMA Optic Neuropathy VF lo
Neuroprotectio!
OBFIOP
PP BP Sclerotic "acular #all
"aopa$ IOP
Mecha!ical%a$a&e
Neutrophin withdrawal
Stopaxoplasmic
flow
Retina ISCHEMIA
ONH
Retina ISCHEMIA
ONH
Vacular %yre&ulatio!
RGC %eath
-
8/17/2019 Glaucoma rs pirngadi
24/30
ATOGENESE
5/1/16 GLAUCOMAZ A L D I
24
-
8/17/2019 Glaucoma rs pirngadi
25/30
$I* "E)'$&A#.(
5/1/16 GLAUCOMAZ A L D I
25
-
8/17/2019 Glaucoma rs pirngadi
26/30
CONGENITAL GLAUCOMA
– $ima$& + au"osomal Bu,#ill#
– S#co)a$& + T$auma/ u,#i"is/ #o!lasma
5/1/16 GLAUCOMAZ A L D I
26
-
8/17/2019 Glaucoma rs pirngadi
27/30
VI)AL -IELD
5/1/16 GLAUCOMAZ A L D I
27
No$malGlaucoma
Glaucoma A*solu"# Glaucoma
-
8/17/2019 Glaucoma rs pirngadi
28/30
RISK FACTORS
• L#,#l o #l#,a"#) IO
• Famil& %is"o$& o .laucoma
• Rac#• A.#
• M&o!ia
• S#;
5/1/16 GLAUCOMAZ A L D I
28
-
8/17/2019 Glaucoma rs pirngadi
29/30
T5ERAY
DRUGS
8#"a a)$##.i9 *loc9#$s 3"imolol/*#"a;olol/ ca$"#olol/ l#,o*ualol/m#"i!$aolol
5&!#$osmo"ic a.#" 3mai"ol/.l&s#$i
As#"a(olami)
M&o"icum
5/1/16 GLAUCOMAZ A L D I
29
-
8/17/2019 Glaucoma rs pirngadi
30/30
REFERENCES
• Am#$ica Aca)#m& o O!%"%almolo.&/ Glaucoma/S#c"io 10/ 2011:2012
• Am#$ica Aca)#m& o O!%"%almolo.&/ E;"#$alDis#as# a) Co$#a/ S#c"io / 2011:2012
• K%u$aa AK/ Com!$#%#si,# O!%"%almolo.&/ Fou$"%E)i"io / N#' D#l%i/ N#' A.# I"#$asioal 3!Limi"#) u*lis%#$/ 200
• Vau.%a As*u$&s + G##$al O!%"%almolo.&
1"% E)i"io / Mc G$a': 5ills Com!ai#s / Ma& 200
5/1/16GLAUCOMAZ A L D I
30